# LRRK2 and Other Novel Exosome Proteins in Parkinson's Disease

> **NCT01860118** · — · COMPLETED · sponsor: **University of Alabama at Birmingham** · enrollment: 601 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01860118
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2016-06-21
- **Final completion:** 2016-06-21
- **Target enrollment:** 601 (ACTUAL)
- **Last updated:** 2018-05-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01860118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01860118, "LRRK2 and Other Novel Exosome Proteins in Parkinson's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01860118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*